Sarepta Therapeutics, Inc. SRPT Incremental Option Value Associated With The December2025Exchange

Incremental Option Value Associated With The December2025Exchange at other companies

General Purpose Acquisition Corp. GPAC

$2.11M—

InsmedINSM

0—

KEE

Keel Infrastructure Corp. Common StockKEEL

$50M—

CHE

ChemedCHE

$2K-98.0%

Carnival CorporationCCL

4M—

Iovance Biotherapeutics, Inc.IOVA

$1K—

Other financials

Income statement

See full

Revenue$730.8M-1.9%

Operating income-$300.4M-961%

Net income$331.0M+174%

EPS (diluted)-$4.60-1,343%

Balance sheet

See full

Cash & equivalents$464.5M+92.8%

Total debt$198.5M-3.4%

Total equity$1.5B+31.7%

Total assets$3.2B-8.3%

Cash flow

See full

Operating cash flow-$202.7M+65.3%

CapEx$2.1M-95.2%

Free cash flow-$204.8M+67.3%

Valuation

See full

Market cap$1.76B-63.1%

Profitability

See full

Operating margin-50.8%-1.6pp

Net margin4.6%+2.4pp

FCF margin-28.7%-9.2pp

Returns & leverage

See full

Return on equity-23.6%-28.5pp

Debt / equity0.1×0.0×

Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept srpt:IncrementalOptionValueAssociatedWithTheDecember2025Exchange.

The official record: Sarepta Therapeutics, Inc.’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s incremental option value associated with the december2025exchange.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s incremental option value associated with the december2025exchange?: Sarepta Therapeutics, Inc. (SRPT) reported incremental option value associated with the december2025exchange of $5.27M in Q4 2025.
What does incremental option value associated with the december2025exchange mean?: Represents the additional fair value attributed to equity-based options or warrants issued or modified during a specific debt exchange transaction. This non-cash adjustment reflects the cost of incentivizing debt holders to participate in restructuring activities. It is a key indicator of the dilution impact and financing costs associated with capital structure management.